ArticleOncoimmunology2025

Immunogenic cell death and bystander killing: expanding the therapeutic potential of modern antibody-drug conjugates.

Oliver Kepp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.